Case report: Area of focus in a case of malignant hypertension

Malignant hypertension (MH) is characterized by severe hypertension (usually grade 3) associated with fundoscopic changes (flame hemorrhages and/or papilledema), microangiopathy and disseminated intravascular coagulation. In addition encephalopathy, acute heart failure and acute deterioration in ren...

Full description

Bibliographic Details
Main Authors: Francesca Gaia Bosisio, Desirè Mingardi, Elisabetta Moretti, Giorgia Muzi, Francesco Russomanno, Nicola Tassani, Deborah Stassaldi, Claudia Agabiti Rosei, Carolina De Ciuceis, Massimo Salvetti, Maria Lorenza Muiesan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1108666/full
_version_ 1797953722986266624
author Francesca Gaia Bosisio
Francesca Gaia Bosisio
Francesca Gaia Bosisio
Desirè Mingardi
Desirè Mingardi
Desirè Mingardi
Elisabetta Moretti
Elisabetta Moretti
Elisabetta Moretti
Giorgia Muzi
Giorgia Muzi
Giorgia Muzi
Francesco Russomanno
Francesco Russomanno
Nicola Tassani
Nicola Tassani
Nicola Tassani
Deborah Stassaldi
Claudia Agabiti Rosei
Claudia Agabiti Rosei
Carolina De Ciuceis
Carolina De Ciuceis
Massimo Salvetti
Massimo Salvetti
Maria Lorenza Muiesan
Maria Lorenza Muiesan
author_facet Francesca Gaia Bosisio
Francesca Gaia Bosisio
Francesca Gaia Bosisio
Desirè Mingardi
Desirè Mingardi
Desirè Mingardi
Elisabetta Moretti
Elisabetta Moretti
Elisabetta Moretti
Giorgia Muzi
Giorgia Muzi
Giorgia Muzi
Francesco Russomanno
Francesco Russomanno
Nicola Tassani
Nicola Tassani
Nicola Tassani
Deborah Stassaldi
Claudia Agabiti Rosei
Claudia Agabiti Rosei
Carolina De Ciuceis
Carolina De Ciuceis
Massimo Salvetti
Massimo Salvetti
Maria Lorenza Muiesan
Maria Lorenza Muiesan
author_sort Francesca Gaia Bosisio
collection DOAJ
description Malignant hypertension (MH) is characterized by severe hypertension (usually grade 3) associated with fundoscopic changes (flame hemorrhages and/or papilledema), microangiopathy and disseminated intravascular coagulation. In addition encephalopathy, acute heart failure and acute deterioration in renal function may be present. The term “malignant” reflects the very poor prognosis for this condition if untreated. When severe hypertension is associated with hypertension-mediated organ damage (HMOD) a life-threatening situation that requires immediate but careful intervention occurs (hypertensive emergency). In the last few years an increase in the number of patients with malignant hypertension has been observed, especially among those patients with black ethnicity. Limited access to treatment and the poor adherence to anti-hypertensive therapy may contribute to the development of hypertensive emergencies. It is considered appropriate to study patients in order to rule out thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. In fact, the microvascular damage caused by malignant hypertension can favor intravascular hemolysis like Thrombotic Microangiopathies (TMs). TMs may present in three different clinical conditions: typical hemolytic uremic syndrome (HUS), atypical hemolytic uremic syndrome (aHUS) and thrombotic thrombocytopenic purpura (TTP). TMs can arise in the context of other pathological processes, including malignant hypertension.
first_indexed 2024-04-10T23:06:36Z
format Article
id doaj.art-49de297551044d39a1ea5750395d33b6
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-10T23:06:36Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-49de297551044d39a1ea5750395d33b62023-01-13T10:44:05ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2023-01-01910.3389/fcvm.2022.11086661108666Case report: Area of focus in a case of malignant hypertensionFrancesca Gaia Bosisio0Francesca Gaia Bosisio1Francesca Gaia Bosisio2Desirè Mingardi3Desirè Mingardi4Desirè Mingardi5Elisabetta Moretti6Elisabetta Moretti7Elisabetta Moretti8Giorgia Muzi9Giorgia Muzi10Giorgia Muzi11Francesco Russomanno12Francesco Russomanno13Nicola Tassani14Nicola Tassani15Nicola Tassani16Deborah Stassaldi17Claudia Agabiti Rosei18Claudia Agabiti Rosei19Carolina De Ciuceis20Carolina De Ciuceis21Massimo Salvetti22Massimo Salvetti23Maria Lorenza Muiesan24Maria Lorenza Muiesan25UOC 2 Medicina, ASST Spedali Civili di Brescia, Brescia, ItalyEmergency Medicine ASST Spedali Civili Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyUOC 2 Medicina, ASST Spedali Civili di Brescia, Brescia, ItalyEmergency Medicine ASST Spedali Civili Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyUOC 2 Medicina, ASST Spedali Civili di Brescia, Brescia, ItalyEmergency Medicine ASST Spedali Civili Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyUOC 2 Medicina, ASST Spedali Civili di Brescia, Brescia, ItalyEmergency Medicine ASST Spedali Civili Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyUOC 2 Medicina, ASST Spedali Civili di Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyUOC 2 Medicina, ASST Spedali Civili di Brescia, Brescia, ItalyEmergency Medicine ASST Spedali Civili Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyUOC 2 Medicina, ASST Spedali Civili di Brescia, Brescia, ItalyUOC 2 Medicina, ASST Spedali Civili di Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyUOC 2 Medicina, ASST Spedali Civili di Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyEmergency Medicine ASST Spedali Civili Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyUOC 2 Medicina, ASST Spedali Civili di Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyMalignant hypertension (MH) is characterized by severe hypertension (usually grade 3) associated with fundoscopic changes (flame hemorrhages and/or papilledema), microangiopathy and disseminated intravascular coagulation. In addition encephalopathy, acute heart failure and acute deterioration in renal function may be present. The term “malignant” reflects the very poor prognosis for this condition if untreated. When severe hypertension is associated with hypertension-mediated organ damage (HMOD) a life-threatening situation that requires immediate but careful intervention occurs (hypertensive emergency). In the last few years an increase in the number of patients with malignant hypertension has been observed, especially among those patients with black ethnicity. Limited access to treatment and the poor adherence to anti-hypertensive therapy may contribute to the development of hypertensive emergencies. It is considered appropriate to study patients in order to rule out thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. In fact, the microvascular damage caused by malignant hypertension can favor intravascular hemolysis like Thrombotic Microangiopathies (TMs). TMs may present in three different clinical conditions: typical hemolytic uremic syndrome (HUS), atypical hemolytic uremic syndrome (aHUS) and thrombotic thrombocytopenic purpura (TTP). TMs can arise in the context of other pathological processes, including malignant hypertension.https://www.frontiersin.org/articles/10.3389/fcvm.2022.1108666/fullmalignant hypertensionhypertensive emergencyorgan damageatypical hemolytic uremic syndromethrombotic microangiopathiesleft ventricular hypertrophy
spellingShingle Francesca Gaia Bosisio
Francesca Gaia Bosisio
Francesca Gaia Bosisio
Desirè Mingardi
Desirè Mingardi
Desirè Mingardi
Elisabetta Moretti
Elisabetta Moretti
Elisabetta Moretti
Giorgia Muzi
Giorgia Muzi
Giorgia Muzi
Francesco Russomanno
Francesco Russomanno
Nicola Tassani
Nicola Tassani
Nicola Tassani
Deborah Stassaldi
Claudia Agabiti Rosei
Claudia Agabiti Rosei
Carolina De Ciuceis
Carolina De Ciuceis
Massimo Salvetti
Massimo Salvetti
Maria Lorenza Muiesan
Maria Lorenza Muiesan
Case report: Area of focus in a case of malignant hypertension
Frontiers in Cardiovascular Medicine
malignant hypertension
hypertensive emergency
organ damage
atypical hemolytic uremic syndrome
thrombotic microangiopathies
left ventricular hypertrophy
title Case report: Area of focus in a case of malignant hypertension
title_full Case report: Area of focus in a case of malignant hypertension
title_fullStr Case report: Area of focus in a case of malignant hypertension
title_full_unstemmed Case report: Area of focus in a case of malignant hypertension
title_short Case report: Area of focus in a case of malignant hypertension
title_sort case report area of focus in a case of malignant hypertension
topic malignant hypertension
hypertensive emergency
organ damage
atypical hemolytic uremic syndrome
thrombotic microangiopathies
left ventricular hypertrophy
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.1108666/full
work_keys_str_mv AT francescagaiabosisio casereportareaoffocusinacaseofmalignanthypertension
AT francescagaiabosisio casereportareaoffocusinacaseofmalignanthypertension
AT francescagaiabosisio casereportareaoffocusinacaseofmalignanthypertension
AT desiremingardi casereportareaoffocusinacaseofmalignanthypertension
AT desiremingardi casereportareaoffocusinacaseofmalignanthypertension
AT desiremingardi casereportareaoffocusinacaseofmalignanthypertension
AT elisabettamoretti casereportareaoffocusinacaseofmalignanthypertension
AT elisabettamoretti casereportareaoffocusinacaseofmalignanthypertension
AT elisabettamoretti casereportareaoffocusinacaseofmalignanthypertension
AT giorgiamuzi casereportareaoffocusinacaseofmalignanthypertension
AT giorgiamuzi casereportareaoffocusinacaseofmalignanthypertension
AT giorgiamuzi casereportareaoffocusinacaseofmalignanthypertension
AT francescorussomanno casereportareaoffocusinacaseofmalignanthypertension
AT francescorussomanno casereportareaoffocusinacaseofmalignanthypertension
AT nicolatassani casereportareaoffocusinacaseofmalignanthypertension
AT nicolatassani casereportareaoffocusinacaseofmalignanthypertension
AT nicolatassani casereportareaoffocusinacaseofmalignanthypertension
AT deborahstassaldi casereportareaoffocusinacaseofmalignanthypertension
AT claudiaagabitirosei casereportareaoffocusinacaseofmalignanthypertension
AT claudiaagabitirosei casereportareaoffocusinacaseofmalignanthypertension
AT carolinadeciuceis casereportareaoffocusinacaseofmalignanthypertension
AT carolinadeciuceis casereportareaoffocusinacaseofmalignanthypertension
AT massimosalvetti casereportareaoffocusinacaseofmalignanthypertension
AT massimosalvetti casereportareaoffocusinacaseofmalignanthypertension
AT marialorenzamuiesan casereportareaoffocusinacaseofmalignanthypertension
AT marialorenzamuiesan casereportareaoffocusinacaseofmalignanthypertension